JMJosiane Machado Vieira Mattoso

Josiane Machado Vieira Mattoso

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Josiane Machado Vieira Mattoso has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparison of Statistical Process Control Models for Monitoring the Biological Burden of a Buffer Solution Used as Input to Produce an Attenuated Viral Vaccine

    by Josiane Machado Vieira Mattoso, Greice Maria Silva da Conceição, Ana Paula Roque da Silva, Paulo Vinicius Pereira Miranda, Letícia de Alencar Pereira Rodrigues, Marcelo Luiz Lima Brandão, Jeancarlo Pereira dos Anjos

    The pharmaceutical industry faces various production challenges. Bioburden control is essential, and appropriate strategies and procedures must be implemented at all stages of production to prevent microbial contamination and comply with regulatory standards. Quality tools can provide important information for data management in production processes. The objective of this study was to compare two types of statistical process control charts (Laney’s U-chart and Bell distribution) in monitoring the bioburden of a buffer solution used as an input to produce an attenuated viral vaccine. Bioburden data for the buffer solution were obtained over a two-year period. The results showed that the analyzed products met the regulatory specifications, as 99% of them presented ≤ 10 colony-forming units (CFU)/100 mL after filtration. Various microorganisms were identified in the buffer solution, including species from the genus Bacillus spp., Micrococcus spp., Kocuria spp., Staphylococcus spp., and Acinetobacter spp. The Bell distribution proved to be statistically more suitable for application in the management of bioburden data for the buffer solution since the limits were closer to the specified value and could more effectively assist in the investigation of process deviations in the production of an attenuated viral vaccine.

  • Quantitative and Qualitative Evaluation of Microorganism Profile Identified in Bioburden Analysis in a Biopharmaceutical Facility in Brazil: Criteria for Classification and Management of Results

    by Josiane Machado Vieira Mattoso, Luciana Veloso da Costa, Bruna de Almeida Do Vale, Cristhiane Falavina dos Reis, Joyce Modesto de Andrade, Lygia Maria Paulo da Silva Braga, Greice Maria Silva da Conceição, Paulo Borges Mathias Costa, Igor Barbosa da Silva, Letícia de Alencar Pereira Rodrigues, et al.

    Microbiological contamination may cause microbial proliferation and consequently additional problems for pharmaceutical companies through production stoppage, product contamination, investigations of process deviations, out-of-specification results and product disposal. This is one of the major concerns of the regulatory health agencies. Microbiological load (bioburden) may represent a potential risk for patients if the sterilization process is not effective and/or due to the production of toxins. Although bioburden can be eliminated by terminal sterilization or filtration processes, it is important to monitor the amount and determine the identity and characteristics of the microorganisms present prior to final processing. The application of microorganism identification systems is crucial for identifying the type of contamination, which can be extremely useful for investigating. The aim of this study was to evaluate the profiles of microorganisms identified in bioburden assays from solutions, culture medias, and products (SCP) from a pharmaceutical industry facility. From 2018-2020, a total of 1,078 samples from 857 different lots of SCP were analyzed and isolated microorganisms were identified. A prefiltering step was included after March 2020, in order to reduce the bioburden before sterilizing filtration. Criteria for the definition and management of microorganisms identified were evaluated after an integrative bibliographic review, and three groups were proposed (critical, objectionable, and nonobjectionable microorganisms). For the samples that did not include prefiltering (n=636), 227 (35.7%) presented microbial growth. For those that included prefiltering, before prefiltering (n=221), 60.6% presented microbial growth, and after prefiltering, this value was reduced to 4.1%, which can be attributed to a contamination during the sampling or a wrong filtering. From the samples that presented microbial growth, 678 microorganisms were identified as bacteria and 59 as molds and yeasts. A total of 120 microorganisms (56 and 27 Gram-positive and negative bacteria, respectively, 31 yeasts, and six filamentous molds) could not be identified, and the remaining microorganisms were classified as objectionable (n=507; 82.2%), nonobjectionable (n=103; 16.7%) and critical (n=7; 1.1%). Most of the bioburden species (>80.0%) were considered objectionable microorganisms. A process for classification and management of bioburden analysis results based on a literature review of pathogenic and physiological characteristics of the microorganisms was proposed.


  • Evaluation of hydrogen peroxide virucidal efficacy against yellow fever virus 17DD vaccine strain for application in a vaccine manufacturing industry

    by Ana Carolina Ferreira Ballestê Ajorio, Vinícius Pessanha Rhodes, Anderson Peclat Rodrigues, Filipe Mercês Moreira, Vanessa Alvaro Diniz, Josiane Machado Vieira Mattoso, Igor Barbosa da Silva, Daniel da Silva Guedes Junior, Marcelo Luiz Lima Brandão